This item requires a subscription to Cardiovascular Research.
Full Text (HTML)
Original Article:
Bee K. Tan,
Raghu Adya,
Jing Chen,
Syed Farhatullah,
Dennis Heutling,
Dan Mitchell,
Hendrik Lehnert,
and Harpal S. Randeva
Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1 Cardiovasc Res (2009)83(3):566-574published ahead of print May 4, 2009 doi:10.1093/cvr/cvp131
To view this item, select one of the options below:
ESC Member and Congress Delegate Sign In
Sign in here for
free online access if your subscription to the Cardiovascular Research
is via the European Society of Cardiology, either as a member* or an ESC Congress delegate.
If your subscription to the Cardiovascular Research is via Oxford University Press, enter your details
below. If this is your first time to use your online subscription, you will need to activate your subscription.
Purchase Short-Term Access
Pay per View
- If you would like to purchase short-term access you must have a personal account.
Please sign in with your personal user name and password or
Register
to obtain a user name name and password for free.
You may access this article for 1 day for US$40.00.